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A modiﬁed technique for placement of the venous outﬂow component (VOC) of the Hemodialysis Reliable Outﬂow
(HeRO) device (Hemosphere Inc, Minneapolis, Minn) is described. The purpose of the technique is to improve the
system’s trackability and facilitate device insertion in patients with central venous occlusion. Device preparation requires
placement of a 6-mm3 4-cm angioplasty balloon within the leading end of the VOC. The leading 2 cm of the balloon are
placed just distal to the radiopaque marker of the VOC. The balloon is inﬂated to proﬁle and locked in this position
within the leading end of the VOC. The VOC and balloon combination is advanced over the wire through the 20F peel-
away sheath provided by the manufacturer. The described technique was used to successfully implant the HeRO device in
12 patients with central venous occlusion. This technique is recommended for placement of the VOC of the HeRO device
in patients with central venous occlusions. (J Vasc Surg 2013;58:1117-9.)Maintenance of reliable, functional long-term vascular
access is critical for hemodialysis and remains a challenge
in current practice.1 Hemodialysis methods include
tunneled central venous catheters, native arteriovenous
ﬁstulas, and synthetic arteriovenous grafts.2 Patients who
require chronic hemodialysis and who have experienced
repeat access failures may require extreme procedures to
preserve vascular access for dialysis such as the placement
of translumbar catheters, tunneled transhepatic catheters,3
and recanalization of occluded veins for dialysis catheter
placement.4 The long-term patency of these tunneled cath-
eters is limited, and furthermore, the use of catheters for
hemodialysis is associated with increased mortality.5
The Hemodialysis Reliable Outﬂow (HeRO) Vascular
Access Device (Hemosphere Inc, Minneapolis, Minn) has
emerged as an alternative for patients with limited vascular
access who depend on dialysis catheters for treatment.6-9
The device consists of two parts: an inﬂow component,
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reinforced nitinol stent. The device is a direct arteriovenous
hemodialysis system. The graft is anastomosed to the
brachial or axillary artery, and the VOC is placed percuta-
neously through either internal jugular vein into the right
atrium. These two parts are tunneled subcutaneously and
connected at the deltopectoral groove using a titanium
connector.8 During dialysis sessions, needles are inserted
into the synthetic graft segment of the system, and the
reinforced nitinol stent provides direct venous outﬂow
into the right atrium.8
The insertion kit for this device includes a 10F dilator,
which is placed within the VOC to provide support during
its insertion (Fig 1, A). As shown in the photograph, there
is a diameter discrepancy between these two pieces. As
pointed out by Glickman,8 this diameter mismatch may
lead to technical difﬁculties during insertion of the VOC,
especially in patients with central venous stenoses or occlu-
sions. The purpose of this report is to describe a modiﬁed,
balloon-assisted technique for placement of the VOC of
theHeRO device in patients with central venous occlusions.
METHODS
This is a retrospective study that was approved by the
Rush University Medical Center Investigational Review
Board. The HeRO device was placed in 14 patients. The
modiﬁed technique was used in 11, and the standard tech-
nique in three. All included patients had history of previ-
ously failed dialysis accesses and central venous occlusions
and were considered unsuitable candidates for hemodialysis
access creation by the vascular access surgeons. Device1117
Fig 1. A, Frontal photograph of the 10F dilator within the venous outﬂow component (VOC) shows the diameter
discrepancy between the two pieces (double arrow). B, Photograph shows venous outﬂow segment preparation. A 6-
mm-diameter by 4-cm-long angioplasty balloon is placed within the VOC of the Hemodialysis Reliable Outﬂow
(HeRO) device, and the balloon is inﬂated to proﬁle.
Fig 2. Spot ﬁlm shows the process of advancing the balloon and
venous outﬂow component (VOC) combination over a wire to its
ﬁnal position within the right atrium.
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alization procedure and (2) HeRO device insertion.
Venous recanalization procedure. The venous recan-
alization procedure was performed under conscious seda-
tion in the angiography suite. We decided to perform the
procedure in two steps because we did not know if recan-
alization would be successful in any given patient. Some of
these recanalization procedures were technically complex
and could take 2 to 3 hours to complete successfully.
Because the recanalization procedure could be performed
under conscious sedation in the angiography suite, we
decided not to spend operating room and anesthesia time
in this part of the process. Once the recanalization was
successfully completed in the interventional radiology suite,
the patient was brought to the operating room the same
day or #24 hours after a successful recanalization.
After ultrasound-guided puncture of either common
femoral vein, a 10F Pinacle vascular sheath (Terumo,
Tokyo, Japan) was inserted to secure vascular access.
Then, a 5F, 90-cm Bernstein catheter (Cook Inc, Bloom-
ington, Ind) and stiff glidewire (Terumo) combination
was used to recanalize the occluded veins using previously
described techniques.10 A temporary Schon dialysis cath-
eter (Angiodynamics, Latham, NY) was inserted through
the recanalized vein with its tip placed within the right
atrium. A femoral, tunneled Duraﬂow hemodialysis cath-
eter (Angiodynamics) was placed through the accessed
common femoral vein in all patients.
VOC implantation using the balloon-assisted
modiﬁed technique. HeRO device placement was per-
formed #24 hours of a successful venous recanalization.
These procedures were performed in the operating room
under general anesthesia. Once the patient was properly
prepared and draped, the temporary dialysis catheter placed
through the recanalized venous segment was removed over
a Bentson angiographic wire (Cook Inc), followed by
placement of a 10F vascular Pinnacle introduction sheath
(Terumo). A 5F, 65-cm Bernstein catheter (Cook Inc)
was used to gain access into the inferior vena cava. A
180-cm Amplatz superstiff guidewire (Boston Scientiﬁc,
Natick, Mass) was then advanced into the inferior vena
cava. A central venogram was performed though the 10Fsheath to evaluate the extent of the venous occlusion.
Angioplasty of the venous occlusion was performed in all
patients using standard 8- to 12-mm-diameter angioplasty
balloons.
The VOC was then prepared for insertion by placing
a 5F, 40-cm-shaft length, 6-mm-diameter by 4-cm-long
angioplasty balloon within the leading end of the VOC
in such a way that the leading 2 cm of the angioplasty
balloon protruded distal to the tip of the VOC. The angio-
plasty balloon was then inﬂated to proﬁle and locked with
a ﬂow switch (Fig 1, B). The insertion was then conducted
by advancing the VOC and balloon combination over the
wire through the 20F peel-away sheath provided in the
device insertion kit. Fluoroscopic guidance was used to
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to its ﬁnal position within the midright atrium (Fig 2).
HeRO device implantation was completed following the
manufacturer’s recommendations.7
RESULTS
A total of 14 patients (8 men, 6 women) underwent
HeRO device placement between August 2009 and
August 2011. The etiology for renal failure was hyper-
tension in eight, hypertension and diabetes in three, and
Goodpasture syndrome, systemic lupus erythematosus,
and dysplastic kidney in one patient each. The mean time
on dialysis was 7.5 years (range, 2-14 years).
Occluded veins included the superior vena cava (SVC)
in seven patients, both subclavian veins and the SVC in
three, both innominate veins in two, both subclavian veins
in one, and occluded metallic stents in both subclavian
veins in one. Veins used for the VOC insertion included
small neck collateral in six, subclavian vein in three, external
jugular vein in three, and internal jugular vein in two. A
total of 11 patients underwent successful HeRO device
VOC implants using the described balloon-assisted tech-
nique. Advancement of the VOC and balloon combination
was always without technical difﬁculties. The standard
implantation technique recommended by the manufacturer
was attempted in three patients. The standard technique
failed in one patient in whom the VOC could not be
advanced across an occluded venous segment. This case
was converted to a modiﬁed balloon-assisted technique,
after which the device was successfully implanted.
One major complication occurred in the standard tech-
nique group. The patient developed severe hypotension
and tachycardia shortly after HeRO device implantation.
According to the operator, VOC implantation had been
technically difﬁcult. An emergency transesophageal echo-
cardiogram showed a large pericardial effusion. The patient
required a pericardial window to restore hemodynamic
stability. The diagnosis was acute tamponade secondary
to SVC damage by the leading edge of the VOC.
DISCUSSION
This report describes a modiﬁed, balloon-assisted tech-
nique for placement of the VOC of the HeRO device inpatients with central venous occlusions. The technique is
simple, and in our opinion, improves the trackability of
the system.8 Only three patients in this series underwent
placement of the device using the standard technique rec-
ommended by the manufacturer. Placement of the VOC
using the standard technique resulted in one major compli-
cation and one insertion failure.
CONCLUSIONS
Our results suggest that the described technique is
useful for the implantation of the VOC of the HeRO
device in patients with central venous occlusion.REFERENCES
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